Emily Crowley

2.4k total citations · 1 hit paper
18 papers, 1.8k citations indexed

About

Emily Crowley is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Emily Crowley has authored 18 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Emily Crowley's work include Drug Transport and Resistance Mechanisms (7 papers), Trace Elements in Health (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). Emily Crowley is often cited by papers focused on Drug Transport and Resistance Mechanisms (7 papers), Trace Elements in Health (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). Emily Crowley collaborates with scholars based in United Kingdom, Italy and Democratic Republic of the Congo. Emily Crowley's co-authors include Alberto Bardelli, Federica Di Nicolantonio, Fotios Loupakis, Richard Callaghan, Ian D. Kerr, Simon Potter, Christopher A. McDevitt, Beth O. Van Emburgh, Megan L. O’Mara and Sandra Misale and has published in prestigious journals such as Biochemistry, Cancer Research and Clinical Cancer Research.

In The Last Decade

Emily Crowley

17 papers receiving 1.8k citations

Hit Papers

Liquid biopsy: monitoring cancer-genetics in the blood 2013 2026 2017 2021 2013 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily Crowley United Kingdom 13 1.0k 834 785 504 246 18 1.8k
Mina Nikanjam United States 19 696 0.7× 658 0.8× 672 0.9× 348 0.7× 182 0.7× 68 1.9k
Kerstin A. David Germany 17 955 0.9× 893 1.1× 546 0.7× 382 0.8× 326 1.3× 36 1.9k
Bruno Robert France 32 1.3k 1.3× 1.4k 1.7× 1.4k 1.8× 552 1.1× 507 2.1× 78 3.3k
Francesca Salvianti Italy 25 930 0.9× 610 0.7× 840 1.1× 309 0.6× 162 0.7× 51 1.6k
Elly Mesman Netherlands 9 662 0.7× 930 1.1× 1.6k 2.1× 338 0.7× 94 0.4× 9 2.7k
Αreti Strati Greece 24 1.1k 1.1× 865 1.0× 1.0k 1.3× 426 0.8× 111 0.5× 48 1.9k
Arutha Kulasinghe Australia 28 933 0.9× 917 1.1× 1.7k 2.1× 607 1.2× 133 0.5× 93 3.1k
Norbert Meidenbauer Germany 18 808 0.8× 1.1k 1.3× 1.5k 1.9× 237 0.5× 58 0.2× 41 3.3k
Michael Saborowski Germany 16 362 0.4× 968 1.2× 1.1k 1.4× 167 0.3× 137 0.6× 26 2.1k
Marina Pajic Australia 28 686 0.7× 1.1k 1.4× 1.5k 1.9× 263 0.5× 120 0.5× 64 2.4k

Countries citing papers authored by Emily Crowley

Since Specialization
Citations

This map shows the geographic impact of Emily Crowley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Crowley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Crowley more than expected).

Fields of papers citing papers by Emily Crowley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Crowley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Crowley. The network helps show where Emily Crowley may publish in the future.

Co-authorship network of co-authors of Emily Crowley

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Crowley. A scholar is included among the top collaborators of Emily Crowley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Crowley. Emily Crowley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Crump, R. E., Emily Crowley, Simon E. F. Spencer, et al.. (2024). Modelling timelines to elimination of sleeping sickness in the Democratic Republic of Congo, accounting for possible cryptic human and animal transmission. Parasites & Vectors. 17(1). 332–332. 2 indexed citations
2.
Antillón, Marina, Paul R. Bessell, Alexandra Shaw, et al.. (2023). Health economic evaluation of strategies to eliminate gambiense human African trypanosomiasis in the Mandoul disease focus of Chad. PLoS neglected tropical diseases. 17(7). e0011396–e0011396. 1 indexed citations
3.
Crump, R. E., Emily Crowley, Andrew Hope, et al.. (2023). A modelling assessment of short- and medium-term risks of programme interruptions for gambiense human African trypanosomiasis in the DRC. PLoS neglected tropical diseases. 17(4). e0011299–e0011299.
4.
Rock, Kat S., R. E. Crump, Paul R. Bessell, et al.. (2022). Update of transmission modelling and projections of gambiense human African trypanosomiasis in the Mandoul focus, Chad. Infectious Diseases of Poverty. 11(1). 11–11. 13 indexed citations
5.
Crowley, Emily, Euphemia Leung, Jóhannes Reynisson, & Alan Richardson. (2020). Rapid changes in the ATG5‐ATG16L1 complex following nutrient deprivation measured using NanoLuc Binary Technology (NanoBIT). FEBS Journal. 287(22). 4917–4932. 4 indexed citations
6.
Crowley, Emily, et al.. (2019). Natural and Synthetic Isothiocyanates Possess Anticancer Potential Against Liver and Prostate Cancer In Vitro. Anticancer Research. 39(7). 3469–3485. 9 indexed citations
7.
Hobor, Sebastijan, Beth O. Van Emburgh, Emily Crowley, et al.. (2014). TGFα and Amphiregulin Paracrine Network Promotes Resistance to EGFR Blockade in Colorectal Cancer Cells. Clinical Cancer Research. 20(24). 6429–6438. 84 indexed citations
8.
Zecchin, Davide, Valentina Boscaro, Enzo Médico, et al.. (2013). BRAF V600E Is a Determinant of Sensitivity to Proteasome Inhibitors. Molecular Cancer Therapeutics. 12(12). 2950–2961. 16 indexed citations
9.
Martini, Miriam, Mariangela Russo, Simona Lamba, et al.. (2013). Mixed Lineage Kinase MLK4 Is Activated in Colorectal Cancers Where It Synergistically Cooperates with Activated RAS Signaling in Driving Tumorigenesis. Cancer Research. 73(6). 1912–1921. 16 indexed citations
10.
Crowley, Emily, Federica Di Nicolantonio, Fotios Loupakis, & Alberto Bardelli. (2013). Liquid biopsy: monitoring cancer-genetics in the blood. Nature Reviews Clinical Oncology. 10(8). 472–484. 1374 indexed citations breakdown →
11.
Crowley, Emily, Sabrina Arena, Simona Lamba, Federica Di Nicolantonio, & Alberto Bardelli. (2013). Targeted Knock-in of the Polymorphism rs61764370 Does Not AffectKRASExpression but Reduces let-7 Levels. Human Mutation. 35(2). 208–214. 15 indexed citations
12.
Crowley, Emily, Megan L. O’Mara, Ian D. Kerr, & Richard Callaghan. (2010). Transmembrane helix 12 plays a pivotal role in coupling energy provision and drug binding in ABCB1. FEBS Journal. 277(19). 3974–3985. 20 indexed citations
13.
Crowley, Emily, Christopher A. McDevitt, & Richard Callaghan. (2009). Generating Inhibitors of P-Glycoprotein: Where to, Now?. Methods in molecular biology. 596. 405–432. 45 indexed citations
14.
Crowley, Emily & Richard Callaghan. (2009). Multidrug efflux pumps: drug binding – gates or cavity?. FEBS Journal. 277(3). 530–539. 28 indexed citations
15.
Crowley, Emily, Megan L. O’Mara, C. Hugh Reynolds, et al.. (2009). Transmembrane Helix 12 Modulates Progression of the ATP Catalytic Cycle in ABCB1. Biochemistry. 48(26). 6249–6258. 28 indexed citations
16.
McDevitt, Christopher A., et al.. (2008). Is ATP binding responsible for initiating drug translocation by the multidrug transporter ABCG2?. FEBS Journal. 275(17). 4354–4362. 36 indexed citations
17.
Callaghan, Richard, et al.. (2007). P‐glycoprotein: So Many Ways to Turn It On. The Journal of Clinical Pharmacology. 48(3). 365–378. 103 indexed citations
18.
Storm, Janet, Megan L. O’Mara, Emily Crowley, et al.. (2007). Residue G346 in Transmembrane Segment Six is Involved in Inter-Domain Communication in P-Glycoprotein. Biochemistry. 46(35). 9899–9910. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026